Clinical Trials Browser

Phase 3 × INDUSTRY × Porfiromycin × Clear all

NCT02183246 2014-07-08

Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients

Phase 3 Terminated

Head and Neck Neoplasms